- Home
- / American Oncology Network
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
American Oncology Network financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$3.1
2024-10-29
Market Capitalization
$41.7 M
2024-10-29
Revenue
$1.8 B
FY, 2024
CreditSafe Score
?
Score changed on Jun 17, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|
| Revenue | 1.3B | 1.8B | ||
| Cost of goods sold | 1.2B | 1.6B | ||
| Gross profit | 82.8M | 117.8M | ||
| Gross profit margin, % | 6.5% | 6.7% | ||
| General and administrative expense | 100.7M | 133.9M | ||
| Operating expense total | 132.0M | 135.3M | ||
| EBIT | (1.6M) | (2.4M) | (49.2M) | (17.4M) |
| EBIT margin, % | -3.8% | -1.0% | ||
| Investment income | (259.0K) | 153.0K | ||
| Interest income | 20.3K | 5.1M | 1.3M | 3.2M |
| Interest expense | 6.4M | 5.7M | ||
| Pre tax profit | 11.6M | (62.5M) | (24.6M) | |
| Income tax expense | 1.0M | 384.0K | 2.5M | |
| Net Income | 8.4M | 10.5M | (63.1M) | (27.0M) |
| EPS | (1.4) | (0.9) |